Loading...

Table of Content

    25 June 2021, Volume 20 Issue 03 Previous Issue    Next Issue
    For Selected: Toggle Thumbnails
    Original articles
    Correlation of KIT and PDGFRA mutation status with clinicopathologic features in primary and recurrent or metastatic gastrointestinal stromal tumors
    GU Yijin, LI Anqi, DONG Lei, XU Haimin, SHEN Xia, XIE Jialing, YUAN Fei, WANG Chaofu
    2021, 20 (03):  257-264.  DOI: 10.16150/j.1671-2870.2021.03.006
    Abstract ( 383 )   HTML ( 3 )   PDF (1385KB) ( 110 )  

    Objective: To investigate the correlation of KIT and PDGFRA mutation status with immunohistochemistry (IHC) and clinicopathological features in the primary, recurren tor metastatic gastrointestinal stromal tumors (GIST). Methods: A total of 167 primary GIST including 22 recurrent or metastatic GIST were tested for CD117, DOG1, CD34 and Ki-67 by IHC, and KIT gene exon 9, 11, 13, 17and PDGFRA gene exon12, 18 were analyzed by Sanger sequencing. Results: The frequencies of KIT and PDGFRA mutation in 167 primary GIST were 83.8%(140/167) and 3.0% (5/167), respectively. The mutation frequencies of KIT gene exon 11, exon 9 and exon 17 were 74.9% (125/167),8.4% (14/167) and 0.6% (1/167). Five primary GIST harbored PDGFRA mutations in exon 18,and 4 tumors had D842V mutation. Genetic mutations in KIT gene included point mutations (34.3%,48/140), deletion mutations (40.7%,57/140), duplication mutations (3.6%,5/140), and complicated mutations (deletion-insertion,12.1%,17/140).For GIST with KIT gene exon 11 mutation, Ki-67 index was significantly higher in tumors with non-point mutation than those with point mutations (P=0.0052). In 22 recurrent or metastatic GIST, double-exon mutation on KIT gene were found in 9 cases and 6 case were with mutation in both exon 11 and 17, 2 in exon 11 and 13,and one in exon 9 and 13.In 22 cases with recurrent or metastatic GIST, patients with double KIT exon mutations had a longer median progression-free survival (PFS)(108 months) than those with wild type gene (PFS, 30 months),and single exon mutation (PFS, 60 months)(P=0.0299 and P=0.0111), while no significant difference were observed regarding Ki-67, CD117, DOG1, CD34 expression,tumor size and nuclear mitosis between them. Conclusions: KIT mutations in primary GIST occur more often in exon 11. For primary GIST with KIT exon 11 mutations, Ki-67 index is higher in lesions with non-point mutation than those with point mutation,indicating poor biological beha-vior. In recurrence or metastatic GIST, cases harbor the double KIT exon mutations account for 9/22 and possess a better PFS than those with wild type and singe KIT exon 11 mutation.

    Figures and Tables | References | Related Articles | Metrics
    Expression of HIF-1α and its relationship with prognosis in papillary renal cell carcinoma
    RUI Wenbin, XU Da, ZHU Yu, WU Yuxuan, WANG Haofei, WANG Chenghe, YUAN Fei
    2021, 20 (03):  265-370.  DOI: 10.16150/j.1671-2870.2021.03.007
    Abstract ( 210 )   HTML ( 2 )   PDF (839KB) ( 71 )  

    Objects: To investigate the expression of hypoxia inducible factor-1ɑ(HIF-1ɑ) in papillary renal cell carcinoma (PRCC) and its relationship with microvessel density so as to explore the correlation of HIF-1ɑ expression with prognosis in PRCC patients. Methods: Immunohistochemistry was used to detect the expression of HIF-1ɑ in PRCC and para-carcinoma tissue and the relationship between expression of HIF-1ɑ and MVD was analyzed. Survival data were eva-luated with Kaplan-Meier and Log-rank method, and the significant factors were further analyzed with Cox model multivariate regression analysis. Results: The positive expression rate of HIF-1ɑ was 42.17% (35/83), and the positive expression rates in typeⅠand type II PRCC were 32.65% and 55.88%, respectively. The MVD in typeⅡPRCC was higher than that in typeⅠPRCC (40.74 /HP vs 25.63/HP), and HIF-1ɑ expression was positively correlated with MVD (γ=0.65). The 5-year survival rate of 83 PRCC patients was 89.16% (74/83), and of the 13 death cases, 10 cases were type Ⅱ PRCC. The Kaplan-Meier survival curve analysis showed that typeⅠPRCC had a better prognosis than typeⅡ. Univariate analysis revealed that Fuhrman grade Ⅲ-Ⅳ, occurrence of distant metastasis and HIF-1ɑ expression were risk factors for prognosis in PRCC patients (P<0.05). Multivariate analysis showed that HIF-1ɑ expression, Fuhrman grade, subtype of PRCC and distant metastasis were risk factors for poor prognosis. Conclusions: HIF-1ɑ expression is higher in typeⅡPRCC than in typeⅠPRCC, and HIF-1ɑ expression is a risk factor for poor prognosis in PRCC patients.

    Figures and Tables | References | Related Articles | Metrics
    Application of high performance liquid chromatography (HPLC) and erythrocyte parameters in the screening of hemoglobinopathy
    WANG Yefei, WU Beiying, XIA Wenquan, HU Yiqun
    2021, 20 (03):  271-278.  DOI: 10.16150/j.1671-2870.2021.03.008
    Abstract ( 252 )   HTML ( 8 )   PDF (1334KB) ( 125 )  

    Objective: To explore the application value of high performance liquid chromatography (HPLC) and erythrocyte parameters for screening of thalassemia in Shanghai. Methods: The hemoglobin of 1 029 samples from patients with suspected thalassemia and with suspected hemolytic anemia were analyzed using HPLC. Genetic analysis of the globin were performed simultaneously with GAP-PCR,reverse dot blot(RDB) and DNA sequencing. Results: Among 1029 samples, 591(57.43%) were diagnosed as having thalassemia and 14 (1.36%) having structural hemoglobin variants.Compared with results of genetic analysis,the sensitivity,specificity,positive predictive value and negative predictive value of HbA2 >3.9% by HPLC as cut-off value for diagnosing β-thalassemia were 95.84%, 96.87%, 95.40%, 97.20%,with AUC of 0.962. When HbA2≤2.1% by HPLC as the cutoff value combined with presence of rapid band were taken for diagnosing α-thalassemia moderate(HbH disease), sensitivity, specificity, positive predictive value, negative predictive value were 96.32%, 52.60%, 100.00 %, with AUC of 0.990. If f HbA2 ≤3.2% by HPLC was taken as the cutoff value for diagnosing minor α-thalassemia or α-thalassemia trait, the corresponding indice were 97.76%, 53.11%, 24.0%, 99.4%,and AUC was 0.753. If MCV≤73.3 fl,MCH≤23.5 pg,MCHC≤324g/L were taken as the cutoff value alone for diagnosing thalassemia, sensitivity and specificity were 87.98%,77.51%, 93.73% and 69.86%, 89.20%,47.61%,respectively. Conclusions: Based on RBC parameters analysis,results of HPLC technology have a good consistence with the resluts of gene detection in the diagnosis of β-thalassemia, HbH disease and structural hemoglobin variant, while a low specificity and positive predictive value may occur in the diagnosis of minor α-thalassemia orα-thalassemia trait.

    Figures and Tables | References | Related Articles | Metrics
    Value of three-dimensional ultrasonic monitoring testicular volume for predicting spermatogenic function in patients with idiopathic hypogonadotropic hypogonadism
    ZHAO Ran, ZHAN Weiwei, LIU Jun
    2021, 20 (03):  279-283.  DOI: 10.16150/j.1671-2870.2021.03.009
    Abstract ( 201 )   HTML ( 3 )   PDF (665KB) ( 77 )  

    Objective: To explore use of three-dimensional ultrasound for predicting spermatogenic function by monitoring testicular volume before and after treatment in patients with idiopathic hypogonadotropic hypogonadism (IHH),and to compare application value with those of changes in sex hormone levels. Methods: A total of 52 male patients with azoospermia due to IHH received micro-pump pulse infusion of gonarelin for 12 weeks in our hospital from January to August 2019 were selected. Patients were divided into 2 groups :spermatogenic groups(15 cases) and non-spermatogenic group (37 cases, including one case of left cryptorchidism). The testicular volume and sex hormones [follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone(T)] levels before and after treatment in the two groups were compared, as well as the semen routine. Results: After 12 weeks of treatment, the overall testicular volume of patients in the spermatogenic group and the non-spermatogenic group increased (P<0.05). The testicular volume before treatment and the increase of serum T level after treatment in the spermatogenic group were higher than those in the non-spermatogenic group (P<0.05). In both spermatogenic group and the non-spermatogenic group, the increase in testicular volume after treatment was positively correlated with the increase in T level (P<0.05), and was not related to FSH, LH level increase (P>0.05). The sensitivity of the right and left testicular volume before treatment to predict spermatogenesis after treatment was 93.33% and 99.8%, and the specificity was 75.68% and 81.08% respectively. The increase in T level before and after treatment for predicting spermatogenesis had a sensitivity of 80% and a specificity of 97.3% after treatment. Conclusions: Testicular volume monitoring with three-dimensional ultrasound before treatment is helpful to predict spermatogenesis in male patients with azoospermia, and sensitivity of which is higher than that of increase in T after treament.

    Figures and Tables | References | Related Articles | Metrics
    Risk factors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes
    HOU Xiaosa, YANG Zhenjiang
    2021, 20 (03):  284-289.  DOI: 10.16150/j.1671-2870.2021.03.010
    Abstract ( 269 )   HTML ( 3 )   PDF (651KB) ( 98 )  

    Objective: To analyze the risk factors for non-sentinel lymph node (nSLN) metastasis in patients with sentinel lymph node-positive breast cancer. Methods: A retrospective analysis was performed on 154 breast cancer patients admitted to our hospital with SLN positive and axillary lymph node dissection. According to weather nSLN metastasis occurred or not, patients were divided into 2 groups : nSLN metastasis negative (nSLN-group,81 cases)and nSLN metastasis positive(nSLN+group,73cases).Univariate and multivariate Logistic regression were used to analyze risk factors for nSLN metastasis. Results: The rate of non-sentinel lymph node metastasis in patients was 47.4% (73/154). Univariate analysis showed that primary tumor T staging, vascular invasion, number of SLN positive, human epidermal growth factor receptor-2, neutrophils/lymphocytes ratio (NLR), and platelets/lymphocytes ratio (PLR) were associated with non-sentinel lymph node metastasis. Further multivariate Logistic regression analysis showed that primary tumor T stage (P=0.040, OR=2.235), NLR (P=0.021, OR=2.073), and number of SLN metastasis (P=0.008, OR=3.763) were independent risk factors for nSLN metastasis. Conclusions: High T stage of primary tumor, NLR>2.82, and the number of SLN>2 are independent risk factors for nSLN metastasis in SLN-metastasis. For patients with risk factors above mentioned,application of axillary lymph node dissection are more important in them.

    Figures and Tables | References | Related Articles | Metrics